Total Payments
$68,338
2024 Payments
$23,378
Companies
16
Transactions
198
Medicare Patients
1,960
Medicare Billing
$243,130
Payment Breakdown by Category
Consulting$35,861 (52.5%)
Other$13,550 (19.8%)
Food & Beverage$10,081 (14.8%)
Travel$8,846 (12.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $35,861 | 25 | 52.5% |
| Honoraria | $10,550 | 3 | 15.4% |
| Food and Beverage | $10,081 | 134 | 14.8% |
| Travel and Lodging | $8,846 | 35 | 12.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,000 | 1 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $32,595 | 119 | $0 (2024) |
| ABIOMED | $13,326 | 16 | $0 (2024) |
| CVRx, Inc. | $8,393 | 20 | $0 (2024) |
| Medtronic Vascular, Inc. | $6,353 | 13 | $0 (2020) |
| Ancora Heart, Inc. | $2,506 | 4 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $2,148 | 1 | $0 (2024) |
| Edwards Lifesciences Corporation | $2,027 | 8 | $0 (2021) |
| Daxor Corporation | $458.88 | 4 | $0 (2024) |
| Medtronic, Inc. | $324.81 | 6 | $0 (2024) |
| ENDOTRONIX, INC. | $58.83 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,378 | 37 | ABIOMED ($12,869) |
| 2023 | $2,598 | 20 | Abbott Laboratories ($1,019) |
| 2022 | $5,625 | 27 | Abbott Laboratories ($3,426) |
| 2021 | $1,554 | 7 | Abbott Laboratories ($1,330) |
| 2020 | $5,897 | 11 | Medtronic Vascular, Inc. ($3,016) |
| 2019 | $2,095 | 15 | Edwards Lifesciences Corporation ($990.06) |
| 2018 | $21,714 | 48 | Abbott Laboratories ($21,534) |
| 2017 | $5,477 | 33 | Abbott Laboratories ($2,895) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABIOMED | Impella (Device) | Honoraria | Cash or cash equivalent | $600.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $2,148.00 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | CVRx, Inc. | Barostim Neo System (Device) | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/21/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $26.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $559.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $77.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $18.95 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $5.00 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/12/2024 | CVRx, Inc. | Barostim Neo System (Device) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/06/2024 | CVRx, Inc. | Barostim Neo System (Device) | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/29/2024 | CVRx, Inc. | Barostim Neo System (Device) | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/26/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Travel and Lodging | In-kind items and services | $61.76 | General |
| Category: Heart Failure | ||||||
| 10/26/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Heart Failure | ||||||
| 10/25/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $86.34 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $42.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/06/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $3.31 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/04/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $156.38 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/04/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $62.79 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/04/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $61.86 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/04/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $57.81 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/04/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $51.28 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/04/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $46.62 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/29/2024 | ABIOMED | Impella (Device) | Honoraria | Cash or cash equivalent | $2,750.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $44.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | ABIOMED | Impella (Device) | Honoraria | Cash or cash equivalent | $7,200.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 407 | 603 | $262,004 | $52,778 |
| 2022 | 15 | 509 | 750 | $284,251 | $62,321 |
| 2021 | 16 | 556 | 856 | $291,136 | $68,016 |
| 2020 | 13 | 488 | 750 | $257,143 | $60,016 |
Total Patients
1,960
Total Services
2,959
Medicare Billing
$243,130
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 175 | $69,020 | $15,545 | 22.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 47 | 87 | $39,211 | $7,960 | 20.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 21 | 38 | $36,628 | $6,204 | 16.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 40 | $22,252 | $5,580 | 25.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 39 | $34,031 | $5,071 | 14.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 39 | $23,221 | $3,914 | 16.9% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Office | 2023 | 18 | 82 | $10,586 | $3,230 | 30.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 34 | $10,666 | $2,083 | 19.5% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 18 | 20 | $9,574 | $1,908 | 19.9% |
| 93750 | Evaluation of lower heart chamber assist device | Office | 2023 | 21 | 32 | $5,936 | $1,102 | 18.6% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 16 | 17 | $878.90 | $180.88 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 150 | $56,805 | $14,693 | 25.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 78 | 139 | $59,214 | $10,984 | 18.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 47 | 47 | $39,099 | $7,262 | 18.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 23 | 40 | $36,560 | $6,746 | 18.5% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Office | 2022 | 28 | 144 | $17,568 | $5,563 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 40 | $21,192 | $5,423 | 25.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 23 | 24 | $13,541 | $2,523 | 18.6% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2022 | 23 | 23 | $10,460 | $2,065 | 19.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 22 | 25 | $5,200 | $1,735 | 33.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 16 | 18 | $5,472 | $1,520 | 27.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 26 | $7,745 | $1,449 | 18.7% |
| 93750 | Evaluation of lower heart chamber assist device | Office | 2022 | 21 | 27 | $4,668 | $1,060 | 22.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 11 | 11 | $4,844 | $907.95 | 18.7% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2022 | 24 | 24 | $1,174 | $258.21 | 22.0% |
About Peter Eckman
Peter Eckman is a Cardiovascular Disease healthcare provider based in Minneapolis, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639131345.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Peter Eckman has received a total of $68,338 in payments from pharmaceutical and medical device companies, with $23,378 received in 2024. These payments were reported across 198 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($35,861).
As a Medicare-enrolled provider, Eckman has provided services to 1,960 Medicare beneficiaries, totaling 2,959 services with total Medicare billing of $243,130. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Minneapolis, MN
- Active Since 04/06/2006
- Last Updated 11/10/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1639131345
Products in Payments
- HeartMate (Device) $18,676
- Impella (Device) $13,326
- Barostim Neo System (Device) $8,393
- HeartMate 3 Left Ventricular Dev (Device) $4,061
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $3,910
- AccuCinch (Device) $2,506
- Kerendia (Drug) $2,148
- CardioMEMS HF System (Device) $2,084
- HeartMate 3 Left Ventricular Assist Device (Device) $1,621
- Circulatory Support (Device) $1,314
- CARDIOMEMS (Device) $601.38
- BVA-100 (Device) $458.88
- HeartWare HVAD (Device) $218.10
- HeartMate Touch (Device) $156.71
- CRT-Ds (Device) $133.80
- Visia AF (Device) $130.66
- Claria MRI (Device) $86.37
- CORDELLA PULOMONARY ARTERY PRESSURE SENSOR (Device) $58.83
- CARDIOHELP (Device) $50.96
- FUROSCIX (Drug) $34.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Minneapolis
Dr. Jeffrey Chambers, M.d, M.D
Cardiovascular Disease — Payments: $3.1M
Cardiovascular Disease $3.1M
Dr. Markus Meyer, M.d, M.D
Cardiovascular Disease — Payments: $716,757
Cardiovascular Disease $716,757
Robert Schwartz, Md, MD
Cardiovascular Disease — Payments: $627,332
Cardiovascular Disease $627,332
Emmanouil Brilakis, Md, MD
Cardiovascular Disease — Payments: $625,583
Cardiovascular Disease $625,583
Robert Van Tassel, Md, MD
Cardiovascular Disease — Payments: $592,604
Cardiovascular Disease $592,604
Dr. Inderjit Anand, Md, Frcp, D Phil, Fa, MD, FRCP, D PHIL, FA
Cardiovascular Disease — Payments: $497,056
Cardiovascular Disease $497,056